Dapsone in the treatment of persistent erythema multiforme

Hoffman, L.D.; Hoffman, M.D.

Journal of Drugs in Dermatology Jdd 5(4): 375-376

2006


ISSN/ISBN: 1545-9616
PMID: 16673809
Document Number: 8656
Erythema multiforme (EM) is usually an acute and self-limited inflammatory reaction of the skin and mucous membranes. Attacks may be sporadic or recurrent, and generally last for 1 to 3 weeks. Rarely, an episode of EM may fail to abate. This continuous and uninterrupted occurrence of typical and atypical lesions is known as persistent EM. We present a case responsive to dapsone.

Document emailed within 1 workday
Secure & encrypted payments

Dapsone in the treatment of persistent erythema multiforme